Europe Making Steady Progress Toward Measles and Rubella Elimination

Europe Making Steady Progress Toward Measles and Rubella Elimination

Saved in:

Bibliographic Details
Main Author:	Editorial Article
Format:	Article
Language:	Russian
Published:	Numikom LLC 2016-12-01
Series:	Эпидемиология и вакцинопрофилактика
Online Access:	https://www.epidemvac.ru/jour/article/view/214
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Europe is Closer than Ever to Eliminating Measles and Rubella
by: Editorial Article
Published: (2016-04-01)

Measles Outbreaks Across Europe Threaten Progress Towards Elimination
by: Editorial Article
Published: (2017-04-01)

Slow progress in measles and rubella elimination in Italy
by: Giovanna Adamo, et al.
Published: (2016-09-01)

Toward Rubella and Congenital Rubella Syndrome Control and Elimination – Worldwide
by: article Editorial
Published: (2019-11-01)

Lessons for sustaining the elimination of measles, rubella, and congenital rubella syndrome in the Caribbean
by: Tracy Evans-Gilbert, et al.
Published: (2024-12-01)

Regional Meeting on Measles and Rubella
by: Editorial article
Published: (2018-04-01)

Progress in Rubella and Congenital Rubella Syndrome Control and Elimination - Worldwide, 2000 - 2016
by: Editorial Article
Published: (2017-12-01)

Progress of Measles and Rubella Surveillance in the Context of Measles Elimination in the WHO Eastern Mediterranean Region, 2019–2022
by: Muhammad Farid, et al.
Published: (2024-11-01)

Measles and rubella in the North-West of Russia in period of elimination
by: M. A. Bichurina, et al.
Published: (2021-12-01)

PROGRAM FOR MEASLES AND RUBELLA ELIMINATION AND CONGENITAL RUBELLA INFECTION PREVENTION IN THE EUROPEAN WHO REGION
by: Ch.K. Aidyralieva
Published: (2009-04-01)

Global challenges and solutions to achieving and sustaining measles and rubella elimination
by: Natasha S. Crowcroft, et al.
Published: (2024-12-01)

ENHANCING KNOWLEDGE AND AWARENESS FOR MEASLES AND RUBELLA ELIMINATION TO PREVENT CONGENITAL RUBELLA SYNDROME IN KULON PROGO AND GUNUNGKIDUL REGENCIES
by: Elisabeth Siti Herini, et al.
Published: (2024-11-01)

The Health and Economic Benefits of United States Investments in Measles and Rubella Control and Elimination
by: Kimberly M. Thompson
Published: (2024-10-01)

COMMENTS ON THE ARTICLE BY C.K. AYDYRALIYEVA «PROGRAM FOR MEASLES AND RUBELLA ELIMINATION AND CONGENITAL RUBELLA INFECTION PREVENTION IN THE EUROPEAN WHO REGION»
by: V.K. Tatochenko
Published: (2009-04-01)

Sustaining measles and rubella elimination through the Regional Monitoring and Re-Verification Commission in the Americas
by: Jon K. Andrus, et al.
Published: (2024-12-01)

Resolution of Regional Meetings on the Improvement of Epidemiological Surveillance of Measles and Rubella in 2017 (with reductions)
by: article Editorial
Published: (2018-06-01)

The Meetings Resolution with the Chief State Sanitary Doctors of CIS Member States "The Main Aspects of the implementation of the Programme of Eliminating Measles and Rubella on the Common Space of the CIS Countries
by: Editorial Article
Published: (2015-12-01)

The National Immunobiological Company Developed a Multivalent Vaccine For Prophylaxis of Measles, Rubella and Parotitis «Vactrivir»
by: Editorial Article
Published: (2017-02-01)

Standards for the Epidemiological Investigation of Measles and Rubella Foci
by: O. V. Tsvirkun, et al.
Published: (2023-05-01)

A journey worth taking: global eradication of measles, rubella and congenital rubella syndrome
by: Jon Kim Andrus, et al.
Published: (2025-12-01)

Manifestations of the Epidemic Process of Measles and Rubella at the Present Stage
by: A. A. Pozdnyakov, et al.
Published: (2018-10-01)

Epidemiology of measles cases, vaccine effectiveness, and performance towards measles elimination in The Gambia.
by: Alieu Sowe, et al.
Published: (2021-01-01)

Epidemiology of Measles and Rubella in Yogyakarta City 2013-2022
by: Dwi Ana Sulistyani, et al.
Published: (2024-07-01)

Domestic Tetravaccine (Measles-Rubella-Mumps) – Immunization of Premature Babies
by: V. V. Semerikov, et al.
Published: (2022-09-01)

Improving the Epidemiological Surveillance of Measles, Rubella and Mumps in the Russian Federation
Published: (2023-01-01)

The State of Specific Immunity to Measles and Rubella Virus in Newborns and their mothers
by: N. T. Tikhonova, et al.
Published: (2017-12-01)

Measles in Europe: Record Number of Both Sick and Immunized
by: article Editorial
Published: (2019-03-01)

Collective Immunity to the Measles, Mumps, and Rubella Viruses in the Kyrgyz Population
by: Anna Yurievna Popova, et al.
Published: (2025-02-01)

Gianotti–Crosti Syndrome Following Measles, Mumps, and Rubella Vaccination
by: Reena Rai, et al.
Published: (2025-01-01)

STATE OF MEASLES, RUBELLA AND MUMPS IN THE SARATOV REGION IN 2001—2013 YEARS
by: T. N. Buchkova, et al.
Published: (2015-08-01)

Topical issues of vaccination and epidemiological surveillance over measles and rubella in Ukraine.
by: G. M. Daragan, et al.
Published: (2018-04-01)

Safety of antibodies to measles, mumps, rubella and diphtheria in patients with juvenile idiopathic arthritis
by: I. V. Fridman, et al.
Published: (2021-07-01)

Timing of Measles, Mumps, and Rubella Vaccination: Secondary Outcomes from an Immunological Survey
by: Jana Zibolenová, et al.
Published: (2025-04-01)

MEASLES-MUMPS-RUBELLA VACCINATION IN A PAEDIATRIC TRANSPLANT PATIENT USING EVEROLIMUS
by: Aybüke Kaçır, et al.
Published: (2025-01-01)

Measles-mumps-rubella-vaccination at 6 months of age induces measles-specific T cell responses: a randomized controlled trial
by: Søren Buus, et al.
Published: (2025-03-01)

Herd Immunity to the Measles, Mumps and Rubella Viruses Among the Belgradian Population in May, 2024
by: Anna Y. Popova, et al.
Published: (2025-06-01)

Characteristics of the epidemic process of measles, rubella and mumps in Moscow and assessment of their seroprevalence at the present stage
by: Yana V. Simakova, et al.
Published: (2025-04-01)

Persistence in epidemic metapopulations: quantifying the rescue effects for measles, mumps, rubella and whooping cough.
by: C Jessica E Metcalf, et al.
Published: (2013-01-01)

Measles–Rubella Microarray Patches Phase III Clinical Trial Framework: Proposal and Considerations
by: Darin Zehrung, et al.
Published: (2024-11-01)

A review of safety and immunogenicity of a novel measles, mumps, rubella (MMR) vaccine
by: Nitin Shah, et al.
Published: (2024-12-01)